For: | Chu JH, Wang H, Ye Y, Chan PK, Pan SY, Fong WF, Yu ZL. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. World J Gastroenterol 2011; 17(19): 2379-2388 [PMID: 21633637 DOI: 10.3748/wjg.v17.i19.2379] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i19/2379.htm |
Number | Citing Articles |
1 |
Chrysoula Boutari, Michail Kokkorakis, Konstantinos Stefanakis, Laura Valenzuela-Vallejo, Evangelos Axarloglou, Špela Volčanšek, Marlene Chakhtoura, Christos S. Mantzoros. Recent research advances in metabolism, clinical and experimental. Metabolism 2023; 149: 155722 doi: 10.1016/j.metabol.2023.155722
|
2 |
Jishuang San, Jianmin Hu, Huiping Pang, Wenjun Zuo, Na Su, Zimeng Guo, Gaofeng Wu, Jiancheng Yang. Taurine Protects against the Fatty Liver Hemorrhagic Syndrome in Laying Hens through the Regulation of Mitochondrial Homeostasis. International Journal of Molecular Sciences 2023; 24(12): 10360 doi: 10.3390/ijms241210360
|
3 |
Pou Kuan Leong, Kam Ming Ko, Pablo Muriel. Schisandrin B: A Double‐Edged Sword in Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/6171658
|
4 |
Yutian Wang, Junzi Wu, Anhua Shi. Literature Review on the Use of Herbal Extracts in the Treatment of Non-
Alcoholic Fatty Liver Disease. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(11): 1123 doi: 10.2174/1871530322666220408123746
|
5 |
Xiao-Yan Wang, Zhi-Ling Yu, Si-Yuan Pan, Yi Zhang, Nan Sun, Pei-Li Zhu, Zhan-Hong Jia, Shu-Feng Zhou, Kam-Ming Ko, Gerhard Litscher. Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/472638
|
6 |
Jie-wei Wang, Xing-yong Wan, Hua-tuo Zhu, Chao Lu, Wei-lai Yu, Chao-hui Yu, Zhe Shen, You-ming Li, Gregory P. Tochtrop. Lipotoxic Effect of p21 on Free Fatty Acid-Induced Steatosis in L02 Cells. PLoS ONE 2014; 9(4): e96124 doi: 10.1371/journal.pone.0096124
|
7 |
Ke Fu, Shu Dai, Cheng Ma, Yafang Zhang, Shenglin Zhang, Cheng Wang, Lihong Gong, Honglin Zhou, Yunxia Li. Lignans are the main active components of
Schisandrae Chinensis Fructus for liver disease treatment: a review
. Food Science and Human Wellness 2024; 13(5): 2425 doi: 10.26599/FSHW.2022.9250200
|
8 |
Ran Ao, Ying Wang, Jing Tong, Bai-Fang Wang. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Medical Science Monitor 2016; 22: 3804 doi: 10.12659/MSM.897207
|
9 |
Ou Wang, Qian Cheng, Jia Liu, Yong Wang, Liang Zhao, Feng Zhou, Baoping Ji. Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice. Food Funct. 2014; 5(11): 3018 doi: 10.1039/C4FO00550C
|
10 |
Li-Shan Yan, Shuo-Feng Zhang, Gan Luo, Brian Chi-Yan Cheng, Chao Zhang, Yi-Wei Wang, Xin-Yu Qiu, Xiao-Hong Zhou, Qing-Gao Wang, Xue-Lan Song, Si-Yuan Pan, Yi Zhang. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism 2022; 131: 155200 doi: 10.1016/j.metabol.2022.155200
|
11 |
Hui Fan, Yuan-yuan Chen, Wei-jian Bei, Lai-you Wang, Bao-tian Chen, Jiao Guo. In VitroScreening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/459390
|
12 |
Qiong Ou-Yang, Chun-xiao Xuan, Xue Wang, Han-qiong Luo, Jin-E Liu, Lan-lan Wang, Ting-ting Li, Yu-peng Chen, Jun Liu. 3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat diet-treated rats by activating AMPK-related pathways. Acta Pharmacologica Sinica 2018; 39(8): 1284 doi: 10.1038/aps.2017.142
|
13 |
Yanwu Hu, Haitao Li, Ruili Li, Yue Tian, Zijing Wu. Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax. Bioengineered 2021; 12(1): 7194 doi: 10.1080/21655979.2021.1979863
|
14 |
Si-Yuan Pan, Shu-Feng Zhou, Si-Hua Gao, Zhi-Ling Yu, Shuo-Feng Zhang, Min-Ke Tang, Jian-Ning Sun, Dik-Lung Ma, Yi-Fan Han, Wang-Fun Fong, Kam-Ming Ko. New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/627375
|
15 |
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic mice. Drug Development Research 2021; doi: 10.1002/ddr.21905
|
16 |
Hiu Yee Kwan, Xuyan Niu, Wenlin Dai, Tiejun Tong, Xiaojuan Chao, Tao Su, Chi Leung Chan, Kim Chung Lee, Xiuqiong Fu, Hua Yi, Hua Yu, Ting Li, Anfernee Kai Wing Tse, Wang Fun Fong, Si-Yuan Pan, Aiping Lu, Zhi-Ling Yu. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers. Scientific Reports 2015; 5(1) doi: 10.1038/srep09114
|
17 |
S. Di Mauro, M. Ragusa, F. Urbano, A. Filippello, A. Di Pino, A. Scamporrino, A. Pulvirenti, A. Ferro, A.M. Rabuazzo, M. Purrello, F. Purrello, S. Piro. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. Nutrition, Metabolism and Cardiovascular Diseases 2016; 26(12): 1129 doi: 10.1016/j.numecd.2016.08.004
|
18 |
Tao Su, Hua Yu, Hiu-Yee Kwan, Xiao-Qing Ma, Hui-Hui Cao, Chi-Yan Cheng, Alexander Kai-Man Leung, Chi-Leung Chan, Wei-Dong Li, Hui Cao, Wang-Fun Fong, Zhi-Ling Yu. Comparisons of the chemical profiles, cytotoxicities and anti-inflammatory effects of raw and rice wine-processed Herba Siegesbeckiae. Journal of Ethnopharmacology 2014; 156: 365 doi: 10.1016/j.jep.2014.09.038
|
19 |
Si-Yuan Pan, Qing Yu, Yi Zhang, Xiao-Yan Wang, Nan Sun, Zhi-Ling Yu, Kam-Ming Ko. Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids in Health and Disease 2012; 11(1) doi: 10.1186/1476-511X-11-120
|
20 |
Nan Sun, Si-Yuan Pan, Yi Zhang, Xiao-Yan Wang, Pei-Li Zhu, Zhu-Sheng Chu, Zhi-Ling Yu, Shu-Feng Zhou, Kam-Ming Ko. Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-46
|
21 |
Tao Su, Brian Chi-Yan Cheng, Xiu-Qiong Fu, Ting Li, Hui Guo, Hui-Hui Cao, Hiu-Yee Kwan, Anfernee Kai-Wing Tse, Hua Yu, Hui Cao, Zhi-Ling Yu. Comparison of the toxicities, bioactivities and chemical profiles of raw and processed Xanthii Fructus. BMC Complementary and Alternative Medicine 2016; 16(1) doi: 10.1186/s12906-016-0994-3
|
22 |
Hiu Yee Kwan, Wang Fun Fong, Zhijun Yang, Zhi-Ling Yu, Wen-Luan Wendy Hsiao. Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells. European Journal of Nutrition 2013; 52(6): 1621 doi: 10.1007/s00394-012-0467-5
|
23 |
Shuo-Shuo Yang, Cheng-Bing Yu, Zhen Luo, Wen-Li Luo, Jing Zhang, Jian-Xiong Xu, Wei-Na Xu. Berberine attenuates sodium palmitate-induced lipid accumulation, oxidative stress and apoptosis in grass carp(Ctenopharyngodon idella)hepatocyte in vitro. Fish & Shellfish Immunology 2019; 88: 518 doi: 10.1016/j.fsi.2019.02.055
|
24 |
Xinshu Xie, Lang Zhang, Shun Yuan, Huilan Li, Chaojun Zheng, Saisai Xie, Yongbing Sun, Changhua Zhang, Rikang Wang, Yi Jin. Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation. Journal of Cellular and Molecular Medicine 2021; 25(3): 1439 doi: 10.1111/jcmm.16229
|
25 |
Xiao-na Hu, Jiao-feng Wang, Yi-qin Huang, Zheng Wang, Fang-yuan Dong, Hai-fen Ma, Zhi-jun Bao. Huperzine A attenuates nonalcoholic fatty liver disease by regulating hepatocyte senescence and apoptosis: an in vitro study. PeerJ 2018; 6: e5145 doi: 10.7717/peerj.5145
|